Tag: Ophthalmic Solution
Paragon BioTeck's FDA Approved Phenylephrine Hydrochloride Ophthalmic Solution Readily Available through Bausch + Lomb
PORTLAND, Ore. /eNewsChannels/ -- NEWS: Paragon BioTeck, Inc., a privately held U.S. biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, announces its FDA approved Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5 percent and 10 percent, to dilate the pupil, is readily available through Bausch + Lomb.
